Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

Valentina Lorenzoni,1 Fabio Baccetti,2 Stefano Genovese,3 Enrico Torre,4 Giuseppe Turchetti1 1Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy; 2SD Diabetology, ASL Toscana Nordovest, Massa Carrara, Italy; 3Cardiovascular and Metabolic Department, IRCCS Multimedica Sesto Sa...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Lorenzoni V (Údar), Baccetti F (Údar), Genovese S (Údar), Torre E (Údar), Turchetti G (Údar)
Formáid: LEABHAR
Foilsithe / Cruthaithe: Dove Medical Press, 2017-11-01T00:00:00Z.
Ábhair:
Rochtain ar líne:Connect to this object online.
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

Connect to this object online.

3rd Floor Main Library

Sonraí sealbhúcháin ó 3rd Floor Main Library
Gairmuimhir: A1234.567
Cóip 1 Ar fáil